Miami Cancer Institute Hematologic Oncology Grand Rounds
Hematologic Oncology Grand Rounds will address the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches. There is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in a thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore has become more complex.
Leaders in the field will be invited to present on recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.
Target Audience
This educational program is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, hematology oncology nurses, pharmacists and other allied health care team members interested in the treatment of patients with hematologic malignancies.
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Learning Objectives
- Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
- Assess and provide updates of new molecular and immunological treatments being developed for these diseases.
- Describe the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
- Identify the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.
Guenther Koehne M.D., Ph.D.
Deputy Director and Chief of Blood & Marrow Transplant,
Hematologic Oncology and Benign Hematology
Guenther Koehne, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-737016, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurse Practitioners, Nurses, Pharmacists, Occupational Therapists and Respiratory Therapists (personal growth). Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Occupational Therapy
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.